AOD-9604: Mechanistic Overview
internal_protocolpreclinical · status: needs_provider_reviewDetails
Author: Axiom Knowledge Base
Citation: Internal reference summary compiled for the Axiom knowledge base (2026).
File: signed link
Summary (generated — provider review required)
AOD-9604 is a modified fragment of growth hormone (hGH 176-191) studied for lipolytic effects. Mechanism: proposed stimulation of lipolysis and inhibition of lipogenesis without significant effect on IGF-1; metabolic/cartilage effects explored in models. Relevance: metabolic phenotypes.
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (4) · phenotypes (0)
evidence_reference, mechanism, safety_reference, dosing_reference
Findings (3) · awaiting review (2)
mechanism · pending
Mechanism: proposed stimulation of lipolysis and inhibition of lipogenesis without significant effect on IGF-1; metabolic/cartilage effects explored in models.
safety · pending
Safety: human efficacy evidence is limited.
dosing · pending
Mechanistic background for provider review only — not a treatment recommendation or dosing guidance.
Processing
Processed into 1 searchable section.